Published in J Biol Chem on September 05, 1997
Regulation of cancer cell metabolism. Nat Rev Cancer (2011) 15.44
RAS oncogenes: weaving a tumorigenic web. Nat Rev Cancer (2011) 6.45
p53 and metabolism. Nat Rev Cancer (2009) 5.05
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer. Br J Cancer (2008) 3.39
Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene (2006) 2.96
Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy. Semin Cancer Biol (2008) 2.93
Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen. J Bioenerg Biomembr (2007) 2.47
Metabolic regulation by p53 family members. Cell Metab (2013) 2.00
p53 regulation of metabolic pathways. Cold Spring Harb Perspect Biol (2009) 1.79
Contribution by different fuels and metabolic pathways to the total ATP turnover of proliferating MCF-7 breast cancer cells. Biochem J (2002) 1.65
Aberrant glycolytic metabolism of cancer cells: a remarkable coordination of genetic, transcriptional, post-translational, and mutational events that lead to a critical role for type II hexokinase. J Bioenerg Biomembr (1997) 1.57
Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology. Front Oncol (2013) 1.42
Ligand-dependent interaction of the glucocorticoid receptor with p53 enhances their degradation by Hdm2. Genes Dev (2001) 1.30
Hexokinase 2-mediated Warburg effect is required for PTEN- and p53-deficiency-driven prostate cancer growth. Cell Rep (2014) 1.29
Genetic insights into OXPHOS defect and its role in cancer. Biochim Biophys Acta (2010) 1.29
Homeostatic functions of the p53 tumor suppressor: regulation of energy metabolism and antioxidant defense. Semin Cancer Biol (2008) 1.27
The Role of p53 in Metabolic Regulation. Genes Cancer (2011) 1.25
The pivotal roles of mitochondria in cancer: Warburg and beyond and encouraging prospects for effective therapies. Biochim Biophys Acta (2010) 1.22
Glucose, not glutamine, is the dominant energy source required for proliferation and survival of head and neck squamous carcinoma cells. Cancer (2011) 1.21
A pivotal role for p53: balancing aerobic respiration and glycolysis. J Bioenerg Biomembr (2007) 1.21
Hypoxia and oxidative stress in breast cancer. Hypoxia and tumourigenesis. Breast Cancer Res (2001) 1.21
Alterations of metabolic genes and metabolites in cancer. Semin Cell Dev Biol (2012) 1.18
p63 regulates glutaminase 2 expression. Cell Cycle (2013) 1.12
Targeting the metabolic microenvironment of tumors. Adv Pharmacol (2012) 1.11
Metabolism and brain cancer. Clinics (Sao Paulo) (2011) 1.10
Conserved transcription factor binding sites of cancer markers derived from primary lung adenocarcinoma microarrays. Nucleic Acids Res (2005) 1.07
The role of p53 in cell metabolism. Acta Pharmacol Sin (2010) 1.03
Negative cross-talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells. EMBO J (2000) 1.01
Individualizing antimetabolic treatment strategies for head and neck squamous cell carcinoma based on TP53 mutational status. Cancer (2011) 1.00
Transcriptional Regulation of SDHa flavoprotein by nuclear respiratory factor-1 prevents pseudo-hypoxia in aerobic cardiac cells. J Biol Chem (2008) 1.00
delta-Catenin promotes prostate cancer cell growth and progression by altering cell cycle and survival gene profiles. Mol Cancer (2009) 0.99
18FDG uptake in oesophageal adenocarcinoma: linking biology and outcome. J Cancer Res Clin Oncol (2007) 0.97
Preferential killing of cancer cells with mitochondrial dysfunction by natural compounds. Mitochondrion (2010) 0.94
Important molecular genetic markers of colorectal cancer. Oncotarget (2016) 0.94
The NAD+ synthesizing enzyme nicotinamide mononucleotide adenylyltransferase 2 (NMNAT-2) is a p53 downstream target. Cell Cycle (2014) 0.92
p53: exercise capacity and metabolism. Curr Opin Oncol (2012) 0.92
Pharmacological activation of p53 in cancer cells. Curr Pharm Des (2011) 0.92
Rapid analysis of glycolytic and oxidative substrate flux of cancer cells in a microplate. PLoS One (2014) 0.91
Lonidamine: basic science and rationale for treatment of prostatic proliferative disorders. Rev Urol (2005) 0.90
NF-κB protein expression associates with (18)F-FDG PET tumor uptake in non-small cell lung cancer: a radiogenomics validation study to understand tumor metabolism. Lung Cancer (2013) 0.90
p53, aerobic metabolism, and cancer. Antioxid Redox Signal (2011) 0.90
Energy metabolism and proliferation in pancreatic carcinogenesis. Langenbecks Arch Surg (2012) 0.89
Metabolic regulation of oxygen and redox homeostasis by p53: lessons from evolutionary biology? Free Radic Biol Med (2012) 0.86
Applications of metabolomics in cancer research. J Carcinog (2013) 0.85
Metabolic, autophagic, and mitophagic activities in cancer initiation and progression. Biomed J (2016) 0.83
Phospho-ΔNp63α/SREBF1 protein interactions: bridging cell metabolism and cisplatin chemoresistance. Cell Cycle (2012) 0.83
Altered metabolism in head and neck squamous cell carcinoma: an opportunity for identification of novel biomarkers and drug targets. Head Neck (2011) 0.82
Altered glucose metabolism in Harvey-ras transformed MCF10A cells. Mol Carcinog (2013) 0.82
The presence of wild type p53 in hematological cancers improves the efficacy of combinational therapy targeting metabolism. Oncotarget (2015) 0.81
p63 supports aerobic respiration through hexokinase II. Proc Natl Acad Sci U S A (2015) 0.81
Regulation of Metabolic Activity by p53. Metabolites (2017) 0.79
Hexokinase 2 is a determinant of neuroblastoma metastasis. Br J Cancer (2016) 0.79
Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters. World J Gastroenterol (2015) 0.79
The role of metabolic therapy in treating glioblastoma multiforme. Surg Neurol Int (2015) 0.78
Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo. Sci Rep (2016) 0.77
Metabolic Reprogramming in Glioma. Front Cell Dev Biol (2017) 0.77
TP53 mutation hits energy metabolism and increases glycolysis in breast cancer. Oncotarget (2016) 0.75
Is p53 Involved in Tissue-Specific Insulin Resistance Formation? Oxid Med Cell Longev (2017) 0.75
The p53 family orchestrates the regulation of metabolism: physiological regulation and implications for cancer therapy. Br J Cancer (2016) 0.75
Tumor suppressor p53 and estrogen receptors in nuclear-mitochondrial communication. Mitochondrion (2013) 0.75
A causal link from ALK to hexokinase II overexpression and hyperactive glycolysis in EML4-ALK-positive lung cancer. Oncogene (2016) 0.75
Differentiation of human neuroblastoma cells toward the osteogenic lineage by mTOR inhibitor. Cell Death Dis (2015) 0.75
Identification of proteins interacting with lactate dehydrogenase in claw muscle of the porcelain crab Petrolisthes cinctipes. Comp Biochem Physiol Part D Genomics Proteomics (2011) 0.75
The role of the p53 tumor suppressor in metabolism and diabetes. J Endocrinol (2016) 0.75
CerS6 Is a Novel Transcriptional Target of p53 Protein Activated by Non-genotoxic Stress. J Biol Chem (2016) 0.75
Mitochondrial determinants of cancer health disparities. Semin Cancer Biol (2017) 0.75
Tumor mitochondria and the bioenergetics of cancer cells. Prog Exp Tumor Res (1978) 3.16
Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene (2006) 2.96
Preparation and characterization of mitochondria and submitochondrial particles of rat liver and liver-derived tissues. Methods Cell Biol (1978) 2.51
Defective protein folding as a basis of human disease. Trends Biochem Sci (1995) 2.22
High aerobic glycolysis of rat hepatoma cells in culture: role of mitochondrial hexokinase. Proc Natl Acad Sci U S A (1977) 2.20
Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase. Cancer Lett (2001) 2.11
Adenosine triphosphatase from rat liver mitochondria. I. Purification, homogeneity, and physical properties. J Biol Chem (1971) 2.04
The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. J Biol Chem (1986) 2.03
Functional significance of mitochondrial bound hexokinase in tumor cell metabolism. Evidence for preferential phosphorylation of glucose by intramitochondrially generated ATP. J Biol Chem (1988) 1.97
Glucose catabolism in cancer cells: identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions. J Biol Chem (2001) 1.84
Determination of microgram quantities of protein in the presence of milligram levels of lipid with amido black 10B. Anal Biochem (1985) 1.75
Energy metabolism of tumor cells. Requirement for a form of hexokinase with a propensity for mitochondrial binding. J Biol Chem (1981) 1.63
Aberrant glycolytic metabolism of cancer cells: a remarkable coordination of genetic, transcriptional, post-translational, and mutational events that lead to a critical role for type II hexokinase. J Bioenerg Biomembr (1997) 1.57
Proton atpases: structure and mechanism. Annu Rev Biochem (1983) 1.52
Hexokinase receptor complex in hepatoma mitochondria: evidence from N,N'-dicyclohexylcarbodiimide-labeling studies for the involvement of the pore-forming protein VDAC. Biochemistry (1986) 1.49
The first nucleotide binding fold of the cystic fibrosis transmembrane conductance regulator can function as an active ATPase. J Biol Chem (1995) 1.48
Phosphate transport in rat liver mitochondria. Kinetics and energy requirements. J Biol Chem (1974) 1.35
A high-yield preparative method for isolation of rat liver mitochondria. Anal Biochem (1977) 1.32
Contributions of glycolysis and oxidative phosphorylation to adenosine 5'-triphosphate production in AS-30D hepatoma cells. Cancer Res (1984) 1.30
The 2.8-A structure of rat liver F1-ATPase: configuration of a critical intermediate in ATP synthesis/hydrolysis. Proc Natl Acad Sci U S A (1998) 1.30
Glucose catabolism in cancer cells: amplification of the gene encoding type II hexokinase. Cancer Res (1996) 1.29
Biochemical and ultrastructural properties of a mitochondrial inner membrane fraction deficient in outer membrane and matrix activities. J Cell Biol (1970) 1.26
Glucose catabolism in cancer cells. Isolation, sequence, and activity of the promoter for type II hexokinase. J Biol Chem (1995) 1.24
Glucose phosphorylation in tumor cells. Cloning, sequencing, and overexpression in active form of a full-length cDNA encoding a mitochondrial bindable form of hexokinase. J Biol Chem (1990) 1.20
Intracellular localization and properties of particulate hexokinase in the Novikoff ascites tumor. Evidence for an outer mitochondrial membrane location. J Biol Chem (1983) 1.20
Diethylstilbestrol. A novel F0-directed probe of the mitochondrial proton ATPase. J Biol Chem (1986) 1.19
Sensitive protein assay in presence of high levels of lipid. Methods Enzymol (1989) 1.19
Cystic fibrosis transmembrane conductance regulator: nucleotide binding to a synthetic peptide. Science (1991) 1.15
The cystic fibrosis transmembrane conductance regulator. Effects of the most common cystic fibrosis-causing mutation on the secondary structure and stability of a synthetic peptide. J Biol Chem (1992) 1.11
Energy-linked anion transport. Cloning, sequencing, and characterization of a full length cDNA encoding the rat liver mitochondrial proton/phosphate symporter. J Biol Chem (1989) 1.11
The kinetics and inhibition of the adenosine diphosphate-adenosine triphosphate exchange catalyzed by purified mitochondrial nucleoside diphosphokinase. J Biol Chem (1967) 1.11
Mitochondrial turnover in animal cells. Half-lives of mitochondria and mitochondrial subfractions of rat liver based on [14C]bicarbonate incorporation. J Biol Chem (1981) 1.11
Glucose phosphorylation. Site-directed mutations which impair the catalytic function of hexokinase. J Biol Chem (1991) 1.09
A translational study "case report" on the small molecule "energy blocker" 3-bromopyruvate (3BP) as a potent anticancer agent: from bench side to bedside. J Bioenerg Biomembr (2012) 1.09
Beta subunit of rat liver mitochondrial ATP synthase: cDNA cloning, amino acid sequence, expression in Escherichia coli, and structural relationship to adenylate kinase. Biochemistry (1988) 1.05
Glucose catabolism in African trypanosomes. Evidence that the terminal step is catalyzed by a pyruvate transporter capable of facilitating uptake of toxic analogs. J Biol Chem (1993) 1.04
Isolation and reconstitution of the n-butylmalonate-sensitive dicarboxylate transporter from rat liver mitochondria. J Biol Chem (1985) 1.03
Purification and characterization of a bindable form of mitochondrial bound hexokinase from the highly glycolytic AS-30D rat hepatoma cell line. Cancer Res (1988) 1.03
Altered protein folding may be the molecular basis of most cases of cystic fibrosis. FEBS Lett (1992) 1.02
Mechanism of action of human P-glycoprotein ATPase activity. Photochemical cleavage during a catalytic transition state using orthovanadate reveals cross-talk between the two ATP sites. J Biol Chem (1998) 1.02
Purification and characterization of the reconstitutively active phosphate transporter from rat liver mitochondria. J Biol Chem (1986) 1.01
Characterization of phosphate efflux pathways in rat liver mitochondria. Biochem J (1983) 1.01
A protein inhibitor of the mitochondrial adenosine triphosphatase complex of rat liver. Purification and characterization. J Biol Chem (1979) 0.99
Modeling of nucleotide binding domains of ABC transporter proteins based on a F1-ATPase/recA topology: structural model of the nucleotide binding domains of the cystic fibrosis transmembrane conductance regulator (CFTR). J Bioenerg Biomembr (1997) 0.99
ATP-dependent reactions catalyzed by inner membrane vesicles of rat liver mitochondria. Kinetics, substrate specificity, and bicarbonate sensitivity. J Biol Chem (1976) 0.99
Proton ATPase of rat liver mitochondria. Preparation and visualization of a functional complex using the novel zwitterionic detergent 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate. J Biol Chem (1984) 0.99
Solubilization and reassembly of the mitochondrial benzodiazepine receptor. Biochemistry (1986) 0.98
Characteristics of phosphate uptake by Ehrlich ascites tumor cells. J Biol Chem (1982) 0.97
Regulation of the mitochondrial ATP synthase/ATPase complex. Arch Biochem Biophys (1986) 0.96
Mitochondrial hexokinase of rat hepatoma cells in culture: solubilization and kinetic properties. Biochemistry (1980) 0.95
Phosphate transport in rat liver mitochondria. Kinetics, inhibitor sensitivity, energy requirements, and labeled components. Mol Cell Biochem (1975) 0.95
Phosphate transport processes in eukaryotic cells. J Membr Biol (1989) 0.94
Cystic fibrosis transmembrane conductance regulator: the purified NBF1+R protein interacts with the purified NBF2 domain to form a stable NBF1+R/NBF2 complex while inducing a conformational change transmitted to the C-terminal region. Arch Biochem Biophys (2000) 0.94
Mitochondrial ATP synthase. Interaction of a synthetic 50-amino acid, beta-subunit peptide with ATP. J Biol Chem (1988) 0.93
Intracellular localization of rat kidney hexokinase. Evidence for an association with low density mitochondria. J Biol Chem (1984) 0.92
Hexokinase: the direct link between mitochondrial and glycolytic reactions in rapidly growing cancer cells. Adv Exp Med Biol (1978) 0.92
Phosphate transport in rat liver mitochondria. Energy-dependent accumulation of phosphate by inverted inner membrane vesicles. J Biol Chem (1978) 0.92
Variants in the dihydropyrimidine dehydrogenase, methylenetetrahydrofolate reductase and thymidylate synthase genes predict early toxicity of 5-fluorouracil in colorectal cancer patients. J Int Med Res (2010) 0.92
Overexpression of higher eukaryotic membrane proteins in bacteria. Novel insights obtained with the liver mitochondrial proton/phosphate symporter. J Biol Chem (1992) 0.91
Adenosine triphosphatase of rat liver mitochondria. Capacity of the homogeneous F1 component of the enzyme to restore ATP synthesis in urea-treated membranes. J Biol Chem (1978) 0.91
Glucose catabolism in brain. Intracellular localization of hexokinase. J Biol Chem (1990) 0.91
Effects of the delta F508 mutation on the structure, function, and folding of the first nucleotide-binding domain of CFTR. J Bioenerg Biomembr (1993) 0.90
Adenosine triphosphatase from rat liver mitochondria. II. Interaction with adenosine diphosphate. J Biol Chem (1972) 0.90
Mitochondrial ATP synthase. Quaternary structure of the F1 moiety at 3.6 A determined by x-ray diffraction analysis. J Biol Chem (1991) 0.90
Localization of oligomycin-sensitive ADP-ATP exchange activity in rat liver mitochondria. Biochem Biophys Res Commun (1968) 0.89
Chemical mechanism of ATP synthase. Magnesium plays a pivotal role in formation of the transition state where ATP is synthesized from ADP and inorganic phosphate. J Biol Chem (1999) 0.89
Mitochondrial ATP synthase. cDNA cloning, amino acid sequence, overexpression, and properties of the rat liver alpha subunit. J Biol Chem (1990) 0.88
Mitochondrial ATPase complex. A dispersed, cytochrome-deficient, oligomycin-sensitive preparation from rat liver containing molecules with a tripartite structural arrangement. J Biol Chem (1979) 0.88
Phosphate transport in rat liver mitochondria. Membrane components labeled by N-ethylmaleimide during inhibition of transport. J Biol Chem (1975) 0.88
Novel insights into the chemical mechanism of ATP synthase. Evidence that in the transition state the gamma-phosphate of ATP is near the conserved alanine within the P-loop of the beta-subunit. J Biol Chem (1997) 0.88
Hexokinase receptors: preferential enzyme binding in normal cells to nonmitochondrial sites and in transformed cells to mitochondrial sites. J Bioenerg Biomembr (1992) 0.88
F0 "proton channel" of rat liver mitochondria. Rapid purification of a functional complex and a study of its interaction with the unique probe diethylstilbestrol. J Biol Chem (1989) 0.87
Structure of the mitochondrial F1 ATPase at 9-A resolution. Proc Natl Acad Sci U S A (1982) 0.87
Cystic fibrosis: a brief look at some highlights of a decade of research focused on elucidating and correcting the molecular basis of the disease. J Bioenerg Biomembr (2001) 0.87
Proton--adenosinetriphosphatase complex of rat liver mitochondria: effect of energy state on its interaction with the adenosinetriphosphatase inhibitory peptide. Biochemistry (1981) 0.86
Adenosine triphosphatase from rat liver mitochondria: separate sites involved in ATP hydrolysis and in the reversible, high affinity binding of ADP. Biochem Biophys Res Commun (1975) 0.86
Rat liver mitochondrial ATP synthase. Effects of mutations in the glycine-rich region of a beta subunit peptide on its interaction with adenine nucleotides. J Biol Chem (1990) 0.86
Protein inhibitor of mitochondrial ATP synthase: relationship of inhibitor structure to pH-dependent regulation. Arch Biochem Biophys (1996) 0.86
Coupling of adenosine triphosphate formation in mitochondria to the formation of nucleoside triphosphates. Involvement of nucleoside diphosphokinase. J Biol Chem (1973) 0.86
Cystic fibrosis transmembrane conductance regulator: the first nucleotide binding fold targets the membrane with retention of its ATP binding function. Biochemistry (1997) 0.86
Adenosine triphosphatase from rat liver mitochondria. Crystallization and x-ray diffraction studies of the F1-component of the enzyme. J Biol Chem (1978) 0.86
The role of mitochondrial hexokinase binding in the abnormal energy metabolism of tumor cell lines. Ann N Y Acad Sci (1986) 0.86
Energy-dependent accumulation of calcium and phosphate by purified inner membrane vesicles of rat liver mitochondria. J Biol Chem (1972) 0.85
Enzymatic and spectral analysis of cytochrome oxidase in adult and fetal rat liver and Morris hepatoma 3924A. Cancer Res (1970) 0.85
Isolation and reconstitution of an N-ethylmaleimide-sensitive phosphate transport protein from rat liver mitochondria. Arch Biochem Biophys (1983) 0.85
ATP synthase. Conditions under which all catalytic sites of the F1 moiety are kinetically equivalent in hydrolyzing ATP. J Biol Chem (1996) 0.84
A comparison of some ultrastructural and biochemical properties of mitochondria from Morris hepatomas 9618A, 7800, and 3924A. Cancer Res (1970) 0.84
Adenosine triphosphatase from rat liver mitochondria. 3. Subunit composition. J Biol Chem (1973) 0.84
Structure/function relationships in hexokinase. Site-directed mutational analyses and characterization of overexpressed fragments implicate different functions for the N- and C-terminal halves of the enzyme. J Biol Chem (1993) 0.84
Isolation of mitochondria from Morris hepatomas. Methods Enzymol (1979) 0.84
The use of thin-layer chromatography on poly(ethyleneimine) cellulose to facilitate assays of ATP-ADP exchange, ATP-Pi exchange, adenylate kinase, and nucleoside diphosphokinase activity. Methods Enzymol (1979) 0.84
Correlation between thymidylate synthase gene variants, RNA and protein levels in primary colorectal adenocarcinomas. J Int Med Res (2010) 0.84
Regulation of the mitochondrial ATP synthase/ATPase complex: cDNA cloning, sequence, overexpression, and secondary structural characterization of a functional protein inhibitor. Arch Biochem Biophys (1993) 0.84
The oligomycin-sensitive adenosine diphosphate-adenosine triphosphate exchange in an inner membrane matrix fraction of rat liver mitochondria. J Biol Chem (1969) 0.83
Mutational analysis of the consensus nucleotide binding sequences in the rat liver mitochondrial ATP synthase beta-subunit. J Biol Chem (1992) 0.83
High-repetition-rate optical parametric chirped-pulse amplifier producing 1-microJ, sub-100-fs pulses in the mid-infrared. Opt Express (2009) 0.83
Effects of phosphotungstic acid and silicotungstic acid on respiration and integrity of rat liver mitochondria. Biochem Biophys Res Commun (1970) 0.82
Adenosine triphosphatase from rat liver mitochondria - evidence for a mercurial-sensitive site for the activating anion bicarbonate. Biochem Biophys Res Commun (1976) 0.82
Subclinical hypothyroidism affects mitochondrial function. Horm Metab Res (2010) 0.82